Abeona Therapeutics Inc (ABEO)
Abeona Therapeutics Inc. (NASDAQ-ABEO) is a healthcare company in the biotechnology sector, and ABEO is its common stock listed on the NASDAQ exchange. The security context is common equity, meaning the instrument represents an ownership interest in the company rather than a fund, note, or other listed product. Abeona Therapeutics Inc. focuses on developing cell and gene therapy candidates for serious medical conditions, with programs aimed at inherited and rare diseases. Its work is centered on research and development rather than broad commercial product categories, so the stock reflects exposure to a clinical-stage biotechnology business.
Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ
Jump directly to the stock analysis sections supported by the latest available data.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Dividend Yield | Next Earnings Date | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-ABEO
|
$6.13
|
5.3% Upside
|
Fair
|
$18.88
|
224.3% Upside
|
Bargain
|
Good
|
0.0%
|
November 16, 2026
|
2.6x
|
13.0x
|
332.8 M
|
205.9 M
|
5.8%
|
64.4%
|
-2.8
|
129.6%
|
